CHS chugs along, INTC among volume kings, TKMR thumped

Chico’s Fas, Inc. (NYSE: CHS) prospered 9.41 percent in price Wednesday to $11.02. Volume was 10,782,229 shares, more than doubling its daily average of 4,519,330. CHS, based in Fort Myers, Fla., Wednesday reported third-quarter net income of $28.8 million, or $0.16 per diluted share, for the third quarter compared to net income of $22.7 million, or $0.13 per diluted share, for last year’s third quarter.

Intel Inc. (NasdaqGS: INTC) had an active Wednesday, trading in 33,245,903 shares, though less than half of its three-month daily average of 68,021,700. The software giant’s shares lost 0.28 percent worth of steam in Wednesday trading to $21.01 just half an hour before the closing bell. INTC announced Wednesday that it has inked a letter of intent with China’s homegrown auto electronics enterprise Hangsheng to jointly set up an auto electronics laboratory,

Tekmira Pharmaceuticals Inc. (NasdaqCM: TKMR) fell in price Wednesday afternoon by 17.02 percent to $5.80. Its volume of 34,300 shares was still nearly double TKMR’s three-month daily average. The Vancouver-based in RNA interference therapeutics announced Monday third-quarter financials, featuring net loss of $2.7 million ($0.26 per common share) as compared to a net loss of $2.8 million ($0.27 per common share) for Q3 2009.

Tags: biopharmaceuticals, CHS, consumer discretionary, INTC, nasdaq, NYSE, pharmaceutical stocks, Technology Stocks, TKMR

This entry was posted on Wednesday, November 17th, 2010 at 4:07 pm by Glenn and is filed under Consumer Discretionary Stocks, Technology Stocks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.